30Jul
Increased regulatory scrutiny of foreign direct investments in the healthcare sector
Key Takeaways - - Foreign Direct Investment (FDI) controls are proliferating around the globe. Since the pandemic, “health” has become a particular focus. - Several countries have adapted their existing FDI rules, or introduced new ones, to address concerns about national autonomy and supply chain disruption. Some of these changes are general, but some are specific to healthcare. - Plans for cross-border M&A in the healthcare sector should take close account of potential FDI screening...
By:
Dechert LLP
Related
For the last thirty years, I have defended companies in OSHA enforcement actions. No matter how larg...
Read More >
On September 24, 2019, the U.S. Department of the Treasury (“Treasury”) published two proposed rul...
Read More >
In today’s edition of Daily Compliance News: Wirecard in the Philippines. (KYC360) Obese politicia...
Read More >
On June 29, 2020, the Japan Fair Trade Commission (“JFTC”) issued a draft of amendments to relevan...
Read More >
The New York Times recently published an article discussing trends in the area of unlawful age discr...
Read More >
Following in the footsteps of its neighbors Maine, Massachusetts, and New Hampshire, Rhode Island re...
Read More >